Study finds Pfizer’s Paxlovid pill does nothing to stop COVID
A study published in the New England Journal of Medicine has shown that Paxlovid has little to no efficacy in treating COVID.

TCS Wire

April 8, 2024

A study published in the New England Journal of Medicine has shown that Paxlovid, Pfizer’s miracle pill that was doled out after people got tired of getting boosters, has little to no efficacy in treating COVID.

Study finds Pfizer’s Paxlovid pill does nothing to stop COVID

According to the recent study, which compared people with or without COVID who took nirmatrelvir–ritonavir (i.e., Paxlovid) or a placebo, “The time to sustained alleviation of all signs and symptoms of Covid-19 did not differ significantly between participants who received nirmatrelvir–ritonavir and those who received placebo.”

The patients who took Paxlovid, unlike the placebo group, also reported a series of side effects. In this case, side effects were mostly limited to dysgeusia and diarrhea; however, several more severe side effects have been reported in the past, especially when taken alongside other medications.

Put simply, despite being initially reported by the Big Pharma company as being safe and 88% effective, Paxlovid is anything but.

The pill was pushed before efficacy was ever ascertained

What’s concerning about this is that the drug has been pushed by world leaders around the world. For instance, Canadian PM Justin Trudeau was extremely bullish on the drug, securing 1 million treatment courses of the drug at the beginning of 2022. Meanwhile, Biden secured a 20 million for unsuspecting Americans.

This isn’t the first time Paxlovid has been shown to be useless, if not outright harmful, either.

The Gateway Pundit has been reporting of its inefficacy practically since it was first released, and following a major report on its lack of efficacy, Pfizer’s CEO, Albert Bourla, was forced to concede this fact.

“While we are disappointed in the outcome of this particular study, these results do not impact the strong efficacy and safety data we’ve observed in our earlier trial for the treatment of COVID-19 patients at high risk of developing severe illness, and we are pleased to see the growing global use of PAXLOVID in that population,” Bourla said. Before this admissions though, he even went so far as claiming to have taken it despite likely knowing of its inefficacy.

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

Trudeau is STILL blaming Stephen Harper for his party’s failures: “Construction takes a while.”

Mike Campbell

April 29, 2024

Trending News

Canada is poised to officially become the most unaffordable place on Earth in terms of housing over the coming months based on Canadians’ income levels and ability to afford rent, mortgages, etc.

Keean Bexte

April 29, 2024

Trending News

Trudeau tells Canadian doctors not to leave because of his tax hike. “It’s not just a nice thing to do, it’s essential to do.”

Mike Campbell

April 26, 2024

Trending News

Between May 3 and 5, 800 army reservists led by the 31 Canadian Brigade Group will join the OPP as part of an operation called the “Trillium Venture”.

Keean Bexte

April 26, 2024

Trending News

“Investigation into these causes is ongoing.” 

TCS Wire

April 26, 2024

Trending News

Australian PM is now calling for a ban on memes, leading to more memes … including one that portrays him as Hitler.

TCS Wire

April 25, 2024

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.